SH3BP1‐induced Rac‐Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SH3BP1‐induced Rac‐Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin

Published:2017-09-18 Issue:2 Volume:119 Page:1733-1745
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Wang Jingjing¹,Feng Yeqian¹,Chen Xishan¹,Du Zheng¹,Jiang Shaijun¹,Ma Shuyun¹,Zou Wen¹^ORCID

Affiliation:

1. Department of Oncology, The Second Xiangya HospitalCentral South UniversityChangshaP.R. China

Funder

Natural Science Foundation of Hunan Province

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.26334

Reference20 articles.

1. Global strategies for cervical cancer prevention

2. Cervical cancer

3. Cell Migration: Integrating Signals from Front to Back

4. RalA and RalB: Antagonistic Relatives in Cancer Cell Migration

5. Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of ARHGAP43(SH3BP1) in acute myeloid leukemia;Journal of the Formosan Medical Association;2024-09

2. PSIP1 promotes gefitinib resistance in lung adenocarcinoma by inducing the expression of WASF3 and its downstream ITGB3/AKT signaling;Clinical and Translational Oncology;2024-07-30

3. A Promising New Model: Establishment of Patient‐Derived Organoid Models Covering HPV‐Related Cervical Pre‐Cancerous Lesions and Their Cancers;Advanced Science;2024-01-16

4. Mechanisms of chemotherapy resistance in cervical cancer;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

5. Drug resistance and immunotherapy in gynecologic cancers;Life Sciences;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3